InspireMD Inc

II2

Company Profile

  • Business description

    InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.

  • Contact

    6303 Waterford District Drive
    Suite 215
    MiamiFL33126
    USA

    T: +1 888 776-6804

    https://www.inspiremd.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2026

    Employees

    127

Stocks News & Analysis

stocks

Wide moat share expects luck to turn

A tough year for jackpots however earnings are expected to normalise.
stocks

ASX share’s growth story intact despite supply constraints

Short term supply challenges but Chinese growth story remains intact.
stocks

ASX healthcare giant rallies despite a fall in profits

Easing investor concerns and signalling a return to growth.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,269.7013.70-0.15%
CAC 408,484.4331.340.37%
DAX 4026,136.56153.520.59%
Dow JONES (US)53,277.01517.800.98%
FTSE 10010,816.5668.400.64%
HKSE26,009.46310.971.21%
NASDAQ26,180.46113.290.43%
Nikkei 22566,016.36200.43-0.30%
NZX 50 Index13,972.6652.840.38%
S&P 5007,674.3733.210.43%
S&P/ASX 2009,058.906.90-0.08%
SSE Composite Index3,905.201.480.04%

Market Movers